BIOVENTUS INC. - CLASS A COMMON STOCK

Bioventus Cancels Proposed $415 Million Offering of Senior Notes; Reaffirms Full-Year 2022 Financial Guidance

03 May 2022 17:47:17 By Nasdaq GlobeNewswire

Bioventus Agrees to Nationwide Contract with Cigna Commercial Plans for DUROLANE® and GELSYN-3® for Knee Osteoarthritis

02 May 2022 07:00:01 By Nasdaq GlobeNewswire

Bioventus Announces Preliminary First Quarter Net Sales and Adjusted EBITDA

26 Apr 2022 09:05:09 By Nasdaq GlobeNewswire

Bioventus Announces $415 Million Offering of Senior Notes

26 Apr 2022 08:38:49 By Nasdaq GlobeNewswire

Bioventus to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022

25 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Bioventus TheraSkin Coverage Expands to Provide for 17 Million More Covered Lives

08 Apr 2022 09:15:08 By Nasdaq GlobeNewswire

Bioventus Announces Inducement Equity to SVP Chief Financial Officer Mark Singleton

05 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Bioventus Exercises Call Option to Acquire CartiHeal

04 Apr 2022 07:00:00 By Nasdaq GlobeNewswire

Bioventus to Present at the Canaccord Genuity Musculoskeletal Conference

16 Mar 2022 07:00:00 By Nasdaq GlobeNewswire

Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

10 Mar 2022 07:00:03 By Nasdaq GlobeNewswire

Bioventus Receives 510(k) Clearance for StimRouter Pain Management Device

01 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Bioventus Appoints Mark Singleton as Chief Financial Officer

28 Feb 2022 07:00:00 By Nasdaq GlobeNewswire

Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

22 Feb 2022 07:00:01 By Nasdaq GlobeNewswire

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

11 Jan 2022 07:00:00 By Nasdaq GlobeNewswire

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

28 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

Bioventus Appoints Michelle McMurry-Heath to Board of Directors

21 Dec 2021 09:25:00 By Nasdaq GlobeNewswire

Bioventus Receives US FDA Clearance for BoneScalpel® Access™

20 Dec 2021 08:30:00 By Nasdaq GlobeNewswire

Bioventus to Expand Operations and Manufacturing in Memphis

18 Nov 2021 08:45:00 By Nasdaq GlobeNewswire

Bioventus Announces Chief Financial Officer Transition Plan

15 Nov 2021 07:30:01 By Nasdaq GlobeNewswire

Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

09 Nov 2021 07:00:02 By Nasdaq GlobeNewswire